Inclusion Criteria:
  -  Over 18 years old - under 70 years old patients with Type 1 diabetes
  -  Those who plan to use CGM G5
  -  Patients who consented to use CGM G5 in conjunction with Clarity
  -  Those who are using multiple insulin injections or insulin pumps for at least 3 months
  -  Those whose fasting c-peptide <0.6 ng / dL, or stimulated c-peptide <1.8 ng / dL
  -  Those with a glycated hemoglobin of 7.0% or more within the last 3 months
  -  Those who have never used a CGM for more than a month
  -  For women of childbearing age, those who agree to use appropriate contraception during the trial
  -  Those who voluntarily signed the agreement after the explanation of the clinical trial
Exclusion Criteria:
  -  Those with a history of severe hypoglycemia and acute ketoacidosis within the last 3 months
  -  Patients with chronic renal function greater than or equal to stage 4 (estimated glomerular filtration rate [assessed by MDRD (modification of diet in renal disease]
     <30 )
  -  Patients with acute myocardial infarction, unstable angina, coronary artery disease or stroke within the last 3 months
  -  Patients with adrenal insufficiency, pituitary dysfunction, medically uncontrolled hyperthyroidism or hypothyroidism
  -  Those taking medications that can affect the glucose metabolism (eg, corticosteroids, immunostimulants, etc.)
  -  Pregnant and lactating women
  -  A person who is deemed unsuitable for participation in clinical trials by examiners